AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry ...

Boron chemistry, particularly the study of metallacarboranes, has emerged as a dynamic field with significant implications for modern medicinal applications. These compounds, characterised by robust ...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron ...

Epetraborole-treated patients demonstrated clinical improvements in QOL-B and a post-hoc analysis of MACrO2 with nominal statistical significance when evaluated as continuous measures First drug ...

Chemists from ETH Zurich have found a way to produce poorly soluble proteins by caging a uniquely reactive boron compound.

The breakthrough could simplify the production of complex proteins used in cancer immunotherapy and other advanced medicines ...

EBO-301 truncated Phase 3 study (n=97) misses primary endpoint; results unable to confirm clinical efficacy observed in Phase 2 study, patients had underlying severe, advanced MAC lung disease ...

Boron cluster chemistry occupies a unique niche in modern chemical science, bridging fundamental inorganic chemistry with practical materials applications. Central to this field is the study of ...

Boron, carbon, nitrogen and oxygen: these four elements can form chemical triple bonds with each other due to their similar electronic properties. Examples of this are the gas carbon monoxide, which ...

Colleagues sometimes called M. Frederick Hawthorne “Mr. Boron,” and it was a nickname he embraced. He often said that boron was his element, but then he’d quickly clarify that it wasn’t that he owned ...

AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced ...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron ...